Linda Simpson‐Herren

1.3k total citations
29 papers, 794 citations indexed

About

Linda Simpson‐Herren is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Linda Simpson‐Herren has authored 29 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Molecular Biology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Linda Simpson‐Herren's work include Estrogen and related hormone effects (5 papers), Retinoids in leukemia and cellular processes (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Linda Simpson‐Herren is often cited by papers focused on Estrogen and related hormone effects (5 papers), Retinoids in leukemia and cellular processes (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Linda Simpson‐Herren collaborates with scholars based in United States. Linda Simpson‐Herren's co-authors include Harris H. Lloyd, J Holmquist, P. E. Noker, Arthur Sanford, Skipper He, Schabel Fm, Griswold Dp, Laster Wr, Rodney Pearlman and Jeffrey P. MacKeigan and has published in prestigious journals such as Cancer Research, Annals of the New York Academy of Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Linda Simpson‐Herren

28 papers receiving 702 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linda Simpson‐Herren United States 15 324 288 158 123 115 29 794
Ellen N. Spremulli United States 14 255 0.8× 258 0.9× 172 1.1× 126 1.0× 48 0.4× 25 687
L. Morasca Italy 17 372 1.1× 238 0.8× 111 0.7× 106 0.9× 57 0.5× 63 850
B Soehnlen United States 11 582 1.8× 513 1.8× 188 1.2× 139 1.1× 65 0.6× 15 1.2k
J. Mills United Kingdom 11 253 0.8× 290 1.0× 172 1.1× 100 0.8× 32 0.3× 21 671
T C Stephens United Kingdom 17 423 1.3× 470 1.6× 151 1.0× 325 2.6× 28 0.2× 52 1.1k
Griswold Dp United States 14 338 1.0× 496 1.7× 95 0.6× 187 1.5× 18 0.2× 19 885
D Glaves United States 19 346 1.1× 381 1.3× 205 1.3× 156 1.3× 88 0.8× 41 988
Antje‐Christine Walz Switzerland 15 402 1.2× 349 1.2× 84 0.5× 89 0.7× 28 0.2× 34 892
Michael Hoeckel Germany 13 349 1.1× 220 0.8× 608 3.8× 225 1.8× 66 0.6× 17 1.2k
Bea Pauwels Belgium 16 439 1.4× 356 1.2× 188 1.2× 209 1.7× 30 0.3× 30 949

Countries citing papers authored by Linda Simpson‐Herren

Since Specialization
Citations

This map shows the geographic impact of Linda Simpson‐Herren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Simpson‐Herren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Simpson‐Herren more than expected).

Fields of papers citing papers by Linda Simpson‐Herren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda Simpson‐Herren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Simpson‐Herren. The network helps show where Linda Simpson‐Herren may publish in the future.

Co-authorship network of co-authors of Linda Simpson‐Herren

This figure shows the co-authorship network connecting the top 25 collaborators of Linda Simpson‐Herren. A scholar is included among the top collaborators of Linda Simpson‐Herren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda Simpson‐Herren. Linda Simpson‐Herren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schabel, F. M. & Linda Simpson‐Herren. (2015). Some Variables in Experimental Tumor Systems which Complicate Interpretation of Data from in vivo Kinetic and Pharmacologic Studies with Anticancer Drugs1. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 23. 113–127.
2.
Niven, Ralph W., Rodney Pearlman, Jeffrey P. MacKeigan, et al.. (1998). Biodistribution of Radiolabeled Lipid–DNA Complexes and DNA in Mice. Journal of Pharmaceutical Sciences. 87(11). 1292–1299. 87 indexed citations
3.
Muccio, Donald D., Wayne J. Brouillette, Theodore R. Breitman, et al.. (1998). Conformationally Defined Retinoic Acid Analogues. 4. Potential New Agents for Acute Promyelocytic and Juvenile Myelomonocytic Leukemias. Journal of Medicinal Chemistry. 41(10). 1679–1687. 46 indexed citations
4.
Lin, Tsu‐Han, Tina S. Rogers, Donald L. Hill, et al.. (1996). Murine Toxicology and Pharmacology of UAB-8, a Conformationally Constrained Analog of Retinoic Acid. Toxicology and Applied Pharmacology. 139(2). 310–316. 2 indexed citations
5.
Vaezi, Michael F., Brahma P. Sani, Tina S. Rogers, et al.. (1994). A Conformationally Defined 6-s-trans-Retinoic Acid Isomer: Synthesis, Chemopreventive Activity, and Toxicity. Journal of Medicinal Chemistry. 37(26). 4499–4507. 16 indexed citations
6.
Simpson‐Herren, Linda & P. E. Noker. (1991). Distribution of Adriamycin in mice bearing mammary adenocarcinoma 16/C. Cell Proliferation. 24(3). 241–255. 2 indexed citations
7.
Simpson‐Herren, Linda & P. E. Noker. (1991). Diversity of penetration of anti‐cancer agents into solid tumours. Cell Proliferation. 24(4). 355–365. 15 indexed citations
8.
Simpson‐Herren, Linda, et al.. (1988). Variability of tumor response to chemotherapy II. Contribution of tumor heterogeneity. Cancer Chemotherapy and Pharmacology. 22(2). 131–304. 39 indexed citations
9.
Noker, P. E., et al.. (1987). Distribution of nitroimidazoles and L-phenylalanine mustard in mammary adenocarcinoma 16/C tumors. Cancer Chemotherapy and Pharmacology. 20(3). 188–192. 3 indexed citations
10.
Simpson‐Herren, Linda, et al.. (1987). Variability of tumor response to chemotherapy I. Contribution of host heterogeneity. Cancer Chemotherapy and Pharmacology. 20(4). 5 indexed citations
11.
He, Skipper & Linda Simpson‐Herren. (1985). Relationship between tumor stem cell heterogeneity and responsiveness to chemotherapy.. PubMed. 63–77. 10 indexed citations
12.
Lloyd, Harris H. & Linda Simpson‐Herren. (1983). Tumor dependence of observed thymidine index as a function of emulsion exposure.. PubMed. 43(3). 1138–44. 1 indexed citations
13.
Simpson‐Herren, Linda. (1982). KINETIC PERTURBATIONS DURING CANCER THERAPY*. Annals of the New York Academy of Sciences. 397(1). 88–100. 6 indexed citations
14.
Simpson‐Herren, Linda, Thomas H. Corbett, & Daniel P. Griswold. (1980). THE CELL POPULATION KINETICS AND RESPONSE TO AN S‐PHASE SPECIFIC AGENT OF THREE TRANSPLANTABLE COLON TUMOR LINES. Cell Proliferation. 13(6). 613–624. 4 indexed citations
15.
Simpson‐Herren, Linda, et al.. (1976). Effects of surgery on the cell kinetics of residual tumor.. PubMed. 60(12). 1749–60. 134 indexed citations
16.
Simpson‐Herren, Linda, et al.. (1976). Ambiguity of the thymidine index.. PubMed. 36(12). 4705–9. 27 indexed citations
17.
Simpson‐Herren, Linda, Arthur Sanford, & J Holmquist. (1974). CELL POPULATION KINETICS OF TRANSPLANTED AND METASTATIC LEWIS LUNG CARCINOMA. Cell Proliferation. 7(4). 349–361. 65 indexed citations
18.
Simpson‐Herren, Linda & Daniel P. Griswold. (1973). Caffeine inhibition of postreplication repair of N-acetoxy-2-acetylaminofluorene-damaged DNA in Chinese hamster cells.. PubMed. 33(10). 2415–24. 6 indexed citations
19.
He, Skipper, et al.. (1972). Basic and therapeutic trial results obtained in the spontaneous AK leukemia (lymphoma) model-end of 1971.. PubMed. 56(3). 273–87, 289. 23 indexed citations
20.
Simpson‐Herren, Linda & Harris H. Lloyd. (1970). Kinetic parameters and growth curves for experimental tumor systems.. PubMed. 54(3). 143–74. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ellen N. Spremulli Breakdown of academic impact, for papers by L. Morasca Breakdown of academic impact, for papers by B Soehnlen Breakdown of academic impact, for papers by J. Mills Breakdown of academic impact, for papers by T C Stephens Breakdown of academic impact, for papers by Griswold Dp Breakdown of academic impact, for papers by D Glaves Breakdown of academic impact, for papers by Antje‐Christine Walz Breakdown of academic impact, for papers by Michael Hoeckel Breakdown of academic impact, for papers by Bea Pauwels
Rankless by CCL
2026